Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ClinicalTrials.gov Requirements Continue To Baffle Firms And Feds Alike

This article was originally published in The Gray Sheet

Executive Summary

Device companies are not the only ones tripped up by the new ClinicalTrials.gov trial registration requirements, as FDA, NIH and others struggle to define what is and is not subject to the law

You may also be interested in...



Unapproved Product Trial Data: To Post Or Not To Post On ClinicalTrials.gov?

Device makers say new clinical trial registration and results reporting requirements should be extended to trials of unapproved products only if the trials were stopped for safety reasons

Unapproved Product Trial Data: To Post Or Not To Post On ClinicalTrials.gov?

Device makers say new clinical trial registration and results reporting requirements should be extended to trials of unapproved products only if the trials were stopped for safety reasons

Final Guidance Names Submissions Subject To ClinicalTrials.gov Certification

Final guidance published Jan. 21 provides answers for device companies still confused about how and when they must certify to FDA that they have registered their clinical trials on ClinicalTrials.gov

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT026238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel